In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic review (2022)
Attributed to:
Therapeutic targeting of fibroblast subsets in inflammatory arthritis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/cts.13457
Publication URI: http://dx.doi.org/10.1111/cts.13457
Type: Journal Article/Review
Parent Publication: Clinical and Translational Science
Issue: 3